Nanomedicine News RSS Feed - Nanomedicine

Kala Initiates Nanotechnology-Based LE-MPP Phase 2 Clinical Trial

Kala Initiates Nanotechnology-Based LE-MPP Phase 2 Clinical Trial

Kala Pharmaceuticals, Inc., a leading developer of innovative nanotechnology-based ophthalmic products leveraging the company’s proprietary Mucus Penetrating Particle (MPP) platform, today announced the initiation of a Phase 2 clinical trial (KPI-121-C-004) to evaluate KP-121, the company’s loteprednol etabonate MPP (“LE-MPP”) drug product, in patients with intraretinal or subretinal fluid secondary to retinal vein occlusion (RVO) or diabetic macular edema (DME). [More]
IBN Develops Gold Nanoprobe Technology for Unlocking Genetic Profiles

IBN Develops Gold Nanoprobe Technology for Unlocking Genetic Profiles

A fast and cost-effective genetic test to determine the correct dosage of blood thinning drugs for the treatment of stroke, heart problems and deep vein thrombosis has been developed by researchers at the Institute of Bioengineering and Nanotechnology (IBN). Using gold nanoprobes, this new technology offers personalized healthcare based on the genetic profile of the patients. [More]
Genomic Medicine Innovator to Serve as Director for Providence Cancer Services and Bioinformatics

Genomic Medicine Innovator to Serve as Director for Providence Cancer Services and Bioinformatics

Today, Providence Health & Services announced that Dr. Patrick Soon-Shiong, a physician, surgeon and scientist known globally for applying collaborative science and technology to improve the health of patients battling life-threatening disease, will serve as the health care system's new global director for cancer services and bioinformatics. [More]
Peptide Nanofiber Scaffold Holds Hope for Intracerebral Hemorrhage Treatment

Peptide Nanofiber Scaffold Holds Hope for Intracerebral Hemorrhage Treatment

Intracerebral hemorrhage is a type of stroke that affects two million people worldwide each year. Despite its seriousness, no effective treatment has yet been developed. But if a recent study in the journal Nanomedicine is right, good news for doctors and patients might one day arrive in a very small package: namely, a “peptide nanofiber scaffold.” [More]
Nanopropellers for Microscopic Medicine

Nanopropellers for Microscopic Medicine

If you thought that the most impressive news in shrinking technology these days was smart watches, think again. Scientists are quietly toiling in their laboratories to create robots that are only nanometers – billionths of a meter – in length, small enough to maneuver inside the human body and possibly inside human cells. [More]
Imbed Bio Awarded NIH SBIR Phase II Grant to Develop Polymeric Nanofilm Dressings with Silver Nanoparticles

Imbed Bio Awarded NIH SBIR Phase II Grant to Develop Polymeric Nanofilm Dressings with Silver Nanoparticles

Imbed Biosciences, Inc, a medical device company developing advanced materials for wound healing and surgical applications, announced today that it has been awarded a $1.5M competitive Small Business Innovation Research (SBIR) Phase II grant from National Institute for Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a division of National Institutes of Health (NIH). [More]
Peer-Reviewed Nanomaterials and Nanotechnology Journal Receives 0.949 Impact Factor

Peer-Reviewed Nanomaterials and Nanotechnology Journal Receives 0.949 Impact Factor

Nanomaterials and Nanotechnology journal has received its first Journal Impact Factor of 0.949 as of July 29th, 2014. Up to this date, all journal's Volumes have been indexed in SCIE and Current Contents databases, as well as in Scopus. [More]
Nanoparticles Jumpstart Body's Ability to Fight Tumors

Nanoparticles Jumpstart Body's Ability to Fight Tumors

Researchers at Dartmouth-Hitchcock Norris Cotton Cancer Center are exploring ways to wake up the immune system so it recognizes and attacks invading cancer cells. Tumors protect themselves by tricking the immune system into accepting everything as normal, even while cancer cells are dividing and spreading. [More]
SapC-DOPS May be Used for Treatment of Brain Cancer

SapC-DOPS May be Used for Treatment of Brain Cancer

Over half of patients being seen in the clinic for a diagnosed brain tumor have metastatic cancer, which has no treatment and detrimental outcomes in most cases. [More]
NanoViricides Dedicates New R&D and cGMP Pilot Manufacturing Facility

NanoViricides Dedicates New R&D and cGMP Pilot Manufacturing Facility

NanoViricides, Inc. celebrated the grand opening of its new R&D and cGMP pilot manufacturing facility with Congressman Jim Himes as the Chief Guest yesterday, July 21. [More]